ReviewMolecular biology reports2025
The functions and regulation of transcription factor YBX1 in cancers.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- YBX1 Promotes Drug Resistance in Hepatocellular Carcinoma and Serves as a Potential Therapeutic Target.Research square · 2026Article
- YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance.Frontiers in immunology · 2026Review
- Human lncRNA, hLinfRNA7 (IDO1-AS) Regulates Cytokine Expression, Tryptophan Catabolism, and Inflammatory Response in Macrophage.Molecular and cellular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
YBX1 is a DNA-binding and RNA-binding protein notable for its evolutionarily conserved cold shock domain. It is located in both the cytoplasm and nucleus and participates in various biological processes, including pre-mRNA splicing, transcription, translation, DNA damage repair, and mRNA stability. Moreover, YBX1 exhibits elevated expression levels across multiple malignancies, and its nuclear translocation is associated with poor cancer prognosis and disease progression. Therefore, elucidating the underlying regulatory mechanisms of YBX1 and its oncogenic role in driving cancer progression is of paramount importance. This review summarizes the diverse physiological functions of YBX1, highlighting its roles and how YBX1 function in various malignancies.
Indexed as
Identifiers
40938464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.